Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ixabepilone + Capecitabine vs Docetaxel + Capecitabine in Metastatic Breast Cancer
NCT00546364Phase 2Terminated
- Sponsor
- R-Pharm
- Start
- Feb 2008
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ixabepilone in breast cancer, sponsored by R-Pharm. Started Feb 2008; status: terminated.
02
Drugs
ixabepilone
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00546364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00546364.